Cargando…
Proton Pump Inhibitors Use and the Risk of Pancreatic Cancer: Evidence from Eleven Epidemiological Studies, Comprising 1.5 Million Individuals
SIMPLE SUMMARY: Proton pump inhibitors are commonly prescribed medications for gastrointestinal disorders, which bring gastric acid down to normal levels. However, the effects of PPI on pancreatic risk remain unclear. Therefore, we conducted a systematic review and meta-analysis to investigate the a...
Autores principales: | Poly, Tahmina Nasrin, Islam, Md. Mohaimenul, Walther, Bruno Andreas, Lin, Ming-Chin, Li, Yu-Chuan (Jack) |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658965/ https://www.ncbi.nlm.nih.gov/pubmed/36358776 http://dx.doi.org/10.3390/cancers14215357 |
Ejemplares similares
-
A Meta-Analysis of Proton Pump Inhibitor Use and the Risk of Acute Kidney Injury: Geographical Differences and Associated Factors
por: Han, Cheng Ta, et al.
Publicado: (2023) -
Use of Mobile Phone App Interventions to Promote Weight Loss: Meta-Analysis
por: Islam, Md Mohaimenul, et al.
Publicado: (2020) -
Artificial Intelligence in Gastric Cancer: Identifying Gastric Cancer Using Endoscopic Images with Convolutional Neural Network
por: Islam, Md. Mohaimenul, et al.
Publicado: (2021) -
Recent Advancement of Clinical Information Systems: Opportunities and Challenges
por: Islam, Md. Mohaimenul, et al.
Publicado: (2018) -
Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies
por: Islam, Md. Mohaimenul, et al.
Publicado: (2020)